MARK A. SR PRYGOCKI

Insider Reports History

Location
Scottsdale, AZ
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARK A. SR PRYGOCKI:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Director Stock Option (right to buy) 20,000 05 Jun 2025 Direct
Clarus Therapeutics Holdings, Inc. Director Common Stock 5,766 07 Jun 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4,805 07 Jun 2022 Direct

Insider Reports Filed by MARK A. SR PRYGOCKI

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRCA Verrica Pharmaceuticals Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:45
VRCA Verrica Pharmaceuticals Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:15
VRCA Verrica Pharmaceuticals Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 09:02
VRCA Verrica Pharmaceuticals Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:18
CRXT Clarus Therapeutics Holdings, Inc. 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 20:06
CRXT Clarus Therapeutics Holdings, Inc. 12 Dec 2021 2 $0 4 Director 14 Dec 2021, 18:03
CRXT Clarus Therapeutics Holdings, Inc. 09 Sep 2021 0 $0 3 Director 13 Sep 2021, 20:35
VRCA Verrica Pharmaceuticals Inc. 10 Jun 2021 1 $0 4/A Director 17 Jun 2021, 16:36